Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-2618
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies ; volume:6 ; number:1 ; day:22 ; month:5 ; year:2018 ; pages:1-13 ; date:12.2018
Microbiome ; 6, Heft 1 (22.5.2018), 1-13, 12.2018
- Urheber
-
Panebianco, Concetta
- Beteiligte Personen und Organisationen
-
Andriulli, Angelo
Pazienza, Valerio
SpringerLink (Online service)
- DOI
-
10.1186/s40168-018-0483-7
- URN
-
urn:nbn:de:101:1-2018080300513703402304
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Panebianco, Concetta
- Andriulli, Angelo
- Pazienza, Valerio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Clinical development of targeted and immune based anti-cancer therapies
Exploiting replication deficiencies to illuminate HIV: host interactions
Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme
Erratum to: miRNAs: micro-managers of anticancer combination therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies
Modern multidisciplinary applied microbiology : exploiting microbes and their interactions
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Clinical development of targeted and immune based anti-cancer therapies
Exploiting replication deficiencies to illuminate HIV: host interactions
Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme
Erratum to: miRNAs: micro-managers of anticancer combination therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies
Modern multidisciplinary applied microbiology : exploiting microbes and their interactions
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Clinical development of targeted and immune based anti-cancer therapies
Exploiting replication deficiencies to illuminate HIV: host interactions
Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme
Erratum to: miRNAs: micro-managers of anticancer combination therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies